Apply for Cancer Control Grants
The Division of Cancer Control and Population Sciences funds a large portfolio of grants and contracts. The portfolio currently includes over 700 grants, valued at nearly $440 million. Here we provide a listing of funding opportunities that are currently accepting applications. Please visit this page regularly as new funding opportunities are added upon approval by NCI.
For information on the portfolio of over 700 grants, please go to Research Portfolios section of this website.
| Title | Announcement # / Mechanism(s) | Activity Code | Clinical Research | Expiration Date | Program Contact | Funding Type | Research Category |
|---|---|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways | NOT-CA-21-019 | February 05, 2023 | Michelle Mollica |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research, Healthcare Delivery Research | ||
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants | PAR-20-074 | R01 | Clinical Trial Not Allowed | October 29, 2022 | Rao Divi |
PAR | Epidemiology and Genomics Research |
| Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations | PAR-21-080 | R01 | Clinical Trial Not Allowed | January 08, 2023 | Curt DellaValle |
PAR | Epidemiology and Genomics Research, Health Disparities |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-314 | UH3 | Clinical Trial Not Allowed | October 11, 2023 | Mukesh Verma |
PAR | Epidemiology and Genomics Research |
| Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science | NOT-OD-21-011 | Robin Vanderpool |
Notices - including Notices of Special Interest (NOSIs) | Health Communication and Informatics Research | |||
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-039 | R01 | Basic Experimental Studies with Humans Required | December 29, 2023 | Scott Rogers |
PAR | Parent and Omnibus Funding Announcements |
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-038 | R01 | Clinical Trial Not Allowed | December 29, 2023 | Scott Rogers |
PAR | Parent and Omnibus Funding Announcements |
| New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center | RFA-CA-20-050 | U24 | Clinical Trial Not Allowed | January 30, 2021 | Somdat Mahabir |
RFA | Epidemiology and Genomics Research |
| New Cohorts for Environmental Exposures and Cancer Risk (CEECR) | RFA-CA-20-049 | UG3, UH3 | Clinical Trial Not Allowed | January 30, 2021 | Somdat Mahabir |
RFA | Epidemiology and Genomics Research |
| Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation | RFA-ES-20-018 | R01 | Clinical Trial Not Allowed | February 02, 2021 | Stefanie Nelson |
RFA | Epidemiology and Genomics Research |
| Notice of Special Interest (NOSI): Health Services Research on Minority Health and Health Disparities | NOT-MD-20-011 | R01 | Clinical Trial Optional | September 08, 2022 | Brenda Adjei |
Notices - including Notices of Special Interest (NOSIs) | Healthcare Delivery Research, Health Disparities |
| Notice of Special Interest (NOSI): Obesity Policy Evaluation Research | NOT-DK-20-035 | Clinical Trial Not Allowed | September 08, 2023 | David Berrigan |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research, Health Behaviors Research | |
| Fertility Status as a Marker for Overall Health | PAR-20-281 | R01 | Clinical Trial Optional | June 20, 2023 | Lisa Gallicchio |
PAR | Epidemiology and Genomics Research |
| Fertility Status as a Marker for Overall Health | PAR-20-282 | R21 | Clinical Trial Not Allowed | June 20, 2023 | Lisa Gallicchio |
PAR | Epidemiology and Genomics Research |
| Investigator-Initiated Research on Genetic Counseling Processes and Practices | RFA-HG-20-048 | R01 | Clinical Trial Optional | July 09, 2021 | Leah Mechanic |
RFA | Epidemiology and Genomics Research, Healthcare Delivery Research |
| Notice of Special Interest (NOSI): Research in the Emergency Setting | NOT-NS-20-005 | September 08, 2022 | Nonniekaye Shelburne |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research, Healthcare Delivery Research | ||
| Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations | RFA-CA-20-051 | R01 | Clinical Trial Required | January 19, 2022 | Kelly Blake |
RFA | Health Behaviors Research, Health Communication and Informatics Research, Health Disparities, Implementation Science, Tobacco Control Research |
| Tobacco Control Policies to Promote Health Equity | PAR-20-302 | R01 | Clinical Trial Optional | September 08, 2023 | Bob Vollinger |
PAR | Tobacco Control Research |
| Tobacco Control Policies to Promote Health Equity | PAR-20-303 | R21 | Clinical Trial Optional | September 08, 2023 | Bob Vollinger |
PAR | Tobacco Control Research |
| NIH Research Project Grant | PA-18-484 | R01 | Clinical Trial Not Allowed | May 08, 2023 | PA | Parent and Omnibus Funding Announcements | |
| Mechanisms and Consequences of Sleep Disparities in the U.S. | PAR-20-164 | R01 | Clinical Trial Not Allowed | July 15, 2022 | PAR | Health Behaviors Research | |
| Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements | PA-18-935 | Clinical Trial Optional | January 25, 2022 | PA, Parent Announcements | |||
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements | PA-18-591 | Clinical Trial Optional | January 26, 2021 | PA, Parent Announcements | |||
| Notice of Amendment of NCI Participation in PAR-20-164, Mechanisms and Consequences of Sleep Disparities in the U.S. | NOT-CA-20-075 | Kara Hall |
Notices - including Notices of Special Interest (NOSIs) | Health Behaviors Research | |||
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences | PAR-20-180 | R01 | Clinical Trial Optional | September 08, 2023 | Bryan Kim |
PAR | Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research |
| Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity | PAR-20-179 | R01 | Clinical Trial Optional | September 08, 2023 | Bryan Kim |
PAR | Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research |
| Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests | PA-17-495 | R01 | Clinical Trial Optional | January 08, 2021 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
PA | Healthcare Delivery Research |
| Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes | PAR-20-211 | K18 | Independent Clinical Trial Not Allowed | March 18, 2023 | Gina Tesauro |
PAR | Basic Biobehavioral and Psychological Sciences |
| Notice of Special Interest (NOSI): Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations | NOT-HG-20-010 | October 05, 2023 | Leah Mechanic 240-276-6847 mechanil@mail.nih.gov |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research | ||
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences | PAR-20-180 | R01 | Clinical Trial Optional | September 08, 2023 | Bryan Kim |
PAR | Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research |
| Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) | PA-20-172 | R01 | Clinical Trial Optional | September 08, 2023 | Sallie J. Weaver (240) 276-6254 sallie.weaver@nih.gov |
PA | Health Disparities, Healthcare Delivery Research |
| Notice of Special Interest (NOSI): Alcohol and Cancer Control | NOT-CA-20-034 | September 09, 2023 | Tanya Agurs-Collins |
Notices - including Notices of Special Interest (NOSIs) | Health Behaviors Research | ||
| NCI Small Grants Program for Cancer Research | PAR-20-052 | R03 | Clinical Trial Optional | January 08, 2023 | PAR, Parent Announcements | Parent and Omnibus Funding Announcements | |
| Co-infection and Cancer | PAR-20-061 | R21 | Clinical Trial Not Allowed | January 08, 2023 | Tram Kim Lam 240-276-6967 lamt@mail.nih.gov |
PAR | Epidemiology and Genomics Research |
| Co-infection and Cancer | PAR-20-062 | R01 | Clinical Trial Not Allowed | January 08, 2023 | Tram Kim Lam 240-276-6967 lamt@mail.nih.gov |
PAR | Epidemiology and Genomics Research |
| Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control | PAR-20-034 | R01 | Clinical Trial Optional | January 08, 2023 | Rebecca Ferrer 301-852-1167 rebecca.ferrer@nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Perception and Cognition Research to Inform Cancer Image Interpretation | PAR-19-387 | R01 | Clinical Trial Optional | January 08, 2023 | Todd Horowitz 240-276-6963 horowitzts@mail.nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Perception and Cognition Research to Inform Cancer Image Interpretation | PAR-19-389 | R21 | Clinical Trial Optional | January 08, 2023 | Todd Horowitz 240-276-6963 horowitzts@mail.nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes | PAR-20-226 | K18 | Basic Experimental Studies with Humans Required | March 18, 2023 | Gina Tesauro 240-276-6786 gina.tesauro@nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery | NOT-CA-20-026 | May 08, 2023 | Wendy Nelson |
Notices - including Notices of Special Interest (NOSIs) | Basic Biobehavioral and Psychological Sciences, Epidemiology and Genomics Research, Healthcare Delivery Research | ||
| Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity | PAR-20-179 | R01 | Clinical Trial Optional | September 08, 2023 | Bryan Kim |
PAR | Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-19-360 | R01 | Clinical Trial Optional | September 08, 2022 | Sarah Kobrin 240-276-6931 kobrins@mail.nih.gov |
PAR | Healthcare Delivery Research, Implementation Science |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-19-358 | R21 | Clinical Trial Optional | September 08, 2022 | Sarah Kobrin 240-276-6931 kobrins@mail.nih.gov |
PAR | Healthcare Delivery Research, Implementation Science |
| Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control | PAR-19-309 | R21 | Clinical Trial Optional | September 08, 2022 | Tanya Agurs-Collins 240-276-6956 collinsta@mail.nih.gov |
PAR | Health Behaviors Research, Implementation Science |
| Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions | NOT-OD-20-106 | September 26, 2022 | Susan Czajkowski 240-276-5871 Susan.Czajkowski@nih.gov |
Notices - including Notices of Special Interest (NOSIs) | Health Behaviors Research | ||
| Integrative Research on Polysubstance Abuse and Disorder | PAR-20-035 | R61, R33 | Clinical Trial Optional | November 08, 2022 | Annette Kaufman 240-276-6706 kaufmana@mail.nih.gov David Berrigan 240-276-6752 berrigad@nih.gov |
PAR | Tobacco Control Research, Health Behaviors Research |
| Core Infrastructure Support for Cancer Epidemiology Cohorts | PAR-20-294 | U01 | Clinical Trial Not Allowed | November 10, 2022 | Joanne Elena |
PAR | Cancer Survivorship, Epidemiology and Genomics Research |
| Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers | NOT-CA-20-022 | January 08, 2023 | Vaurice Starks |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research | ||
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research | RFA-OD-20-011 | K01 | Independent Clinical Trial Required | July 11, 2022 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research | RFA-OD-20-008 | K01 | Independent Clinical Trial Not Allowed | July 11, 2022 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-19-359 | R03 | Clinical Trial Optional | July 17, 2022 | Sarah Kobrin 240-276-6931 kobrins@mail.nih.gov |
PAR | Healthcare Delivery Research, Implementation Science |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization | PAR-19-352 | R01 | Clinical Trial Optional | September 08, 2022 | Michelle Mollica 240-276-7621 mollicama@mail.nih.gov |
PAR | Cancer Survivorship |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization | PAR-19-355 | R21 | Clinical Trial Optional | September 08, 2022 | Michelle Mollica 240-276-7621 mollicama@mail.nih.gov |
PAR | Cancer Survivorship |
| Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) | PAR-19-276 | R03 | May 08, 2022 | Gila Neta 240-276-6785 netagil@mail.nih.gov Cynthia A. Vinson 240-276-6745 cvinson@mail.nih.gov |
PAR | Implementation Science | |
| Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | NOT-CA-20-025 | May 08, 2022 | Mark Parascandola 240-276-6871 paramark@mail.nih.gov |
Notices - including Notices of Special Interest (NOSIs) | Tobacco Control Research, Health Behaviors Research, Health Disparities, Implementation Science | ||
| Notice of Special Interest (NOSI): De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum | NOT-CA-20-021 | May 10, 2022 | Erica Breslau |
Notices - including Notices of Special Interest (NOSIs) | Implementation Science | ||
| Neural Regulation of Cancer | PAR-19-353 | R01 | Clinical Trial Not Allowed | May 28, 2022 | Chamelli Jhappan jhappanc@mail.nih.gov Paige Green 240-276-6899 paige.green@nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Neural Regulation of Cancer | PAR-19-354 | R21 | Clinical Trial Not Allowed | May 28, 2022 | Chamelli Jhappan jhappanc@mail.nih.gov Paige Green 240-276-6899 paige.green@nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment | PAR-19-340 | R01 | Clinical Trial Optional | June 09, 2022 | Todd Horowitz 240-276-6963 horowitzts@mail.nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences, Cancer Survivorship |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment | PAR-19-339 | R21 | Clinical Trial Optional | June 09, 2022 | Todd Horowitz 240-276-6963 horowitzts@mail.nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences, Cancer Survivorship |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem | PAR-19-348 | R01 | Clinical Trial Optional | June 09, 2022 | Kelly Blake 240-281-5934 kelly.blake@nih.gov |
PAR | Health Communication and Informatics Research |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem | PAR-19-350 | R21 | Clinical Trial Optional | June 09, 2022 | Kelly Blake 240-281-5934 kelly.blake@nih.gov |
PAR | Health Communication and Informatics Research |
| Pathway to Independence Award in Tobacco Regulatory Research | RFA-OD-20-010 | K99, R00 | Independent Clinical Trial Required | July 11, 2022 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Pathway to Independence Award in Tobacco Regulatory Research | RFA-OD-20-009 | K99, R00 | Independent Clinical Trial Not Allowed | July 11, 2022 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations | PA-18-932 | R01 | Clinical Trial Optional | January 08, 2022 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
PA | Healthcare Delivery Research, Implementation Science |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies | PAR-19-325 | R01 | Clinical Trial Optional | February 12, 2022 | Kelly Filipski 240-276-6841 Filipskikk@mail.nih.gov |
PAR | Epidemiology and Genomics Research, Cancer Survivorship |
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer | PAR-20-088 | R01 | Clinical Trial Not Allowed | April 02, 2022 | Tram Kim Lam 240-276-6967 lamt@mail.nih.gov |
PAR | Health Disparities, Epidemiology and Genomics Research |
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer | PAR-20-081 | R21 | Clinical Trial Not Allowed | April 02, 2022 | Tram Kim Lam 240-276-6967 lamt@mail.nih.gov |
PAR | Health Disparities, Epidemiology and Genomics Research |
| Biology of Bladder Cancer | PAR-19-184 | R21 | Clinical Trial Optional | May 08, 2022 | Tram Kim Lam 240-276-6967 lamt@mail.nih.gov |
PAR | Epidemiology and Genomics Research |
| Biology of Bladder Cancer | PAR-19-183 | R01 | Clinical Trial Optional | May 08, 2022 | Tram Kim Lam 240-276-6967 lamt@mail.nih.gov |
PAR | Epidemiology and Genomics Research |
| Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) | PAR-19-274 | R01 | Clinical Trial Optional | May 08, 2022 | Gila Neta 240-276-6785 netagil@mail.nih.gov Cynthia A. Vinson 240-276-6745 cvinson@mail.nih.gov |
PAR | Implementation Science |
| Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) | PAR-19-275 | R21 | Clinical Trial Optional | May 08, 2022 | Gila Neta 240-276-6785 netagil@mail.nih.gov Cynthia A. Vinson 240-276-6745 cvinson@mail.nih.gov |
PAR | Implementation Science |
| Exploratory Grants in Cancer Epidemiology and Genomics Research | PAR-19-277 | R21 | Clinical Trial Optional | October 09, 2021 | Mukesh Verma 240-276-6889 vermam@mail.nih.gov |
PAR | Epidemiology and Genomics Research |
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | PA-19-112 | R01 | Clinical Trial Optional | January 08, 2022 | Nonniekaye Shelburne 240-276-6897 nshelburne@mail.nih.gov |
PA | Epidemiology and Genomics Research, Cancer Survivorship |
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | PA-19-111 | R21 | Clinical Trial Optional | January 08, 2022 | Nonniekaye Shelburne 240-276-6897 nshelburne@mail.nih.gov |
PA | Epidemiology and Genomics Research, Cancer Survivorship |
| Notice of Special Interest (NOSI): Geospatial Approaches in Cancer Control and Population Sciences | NOT-CA-20-004 | January 08, 2022 | Armen Ghazarian |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research, Health Communication and Informatics Research | ||
| Notice of Special Interest (NOSI): Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk | NOT-CA-20-002 | January 08, 2022 | Stefanie Nelson |
Notices - including Notices of Special Interest (NOSIs) | Epidemiology and Genomics Research | ||
| Notice of Special Interest (NOSI): NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment | NOT-CA-19-059 | January 08, 2022 | Sallie J. Weaver 240-276-6254 sallie.weaver@nih.gov Veronica Chollette 240-276-6969 cholletv@mail.nih.gov |
Notices - including Notices of Special Interest (NOSIs) | Healthcare Delivery Research, Cancer Survivorship | ||
| End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses | PAR-19-136 | R01 | Clinical Trial Optional | January 08, 2022 | Ashley Wilder Smith 240-276-6714 smithas@mail.nih.gov |
PAR | Healthcare Delivery Research, Cancer Survivorship |
| End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses | PAR-19-153 | R21 | Clinical Trial Optional | January 08, 2022 | Ashley Wilder Smith 240-276-6714 smithas@mail.nih.gov |
PAR | Healthcare Delivery Research, Cancer Survivorship |
| Time-Sensitive Obesity Policy and Program Evaluation | PAR-18-854 | R01 | September 11, 2021 | David Berrigan 240-276-6752 David.Berrigan@nih.gov Jill Reedy 240-276-6812 reedyj@mail.nih.gov |
PAR | Health Behaviors Research, Epidemiology and Genomics Research | |
| End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness | PA-18-499 | R21 | Clinical Trial Optional | May 08, 2021 | Sylvia Chou 240-276-6954 chouws@mail.nih.gov |
PA | Health Communication and Informatics Research, Cancer Survivorship |
| Native American Research Centers for Health (NARCH) | PAR-20-125 | S06 | Clinical Trial Optional | July 24, 2021 | Shobha Srinivasan 240-276-6938 sriniva2@mail.nih.gov |
PAR | Health Disparities |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors | RFA-CA-20-027 | R01 | Clinical Trial Optional | July 31, 2021 | Michelle Mollica |
RFA | Cancer Survivorship, Epidemiology and Genomics Research, Healthcare Delivery Research |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors | RFA-CA-20-028 | R21 | Clinical Trial Optional | July 31, 2021 | Michelle Mollica |
RFA | Cancer Survivorship, Epidemiology and Genomics Research, Healthcare Delivery Research |
| Notice of NCI's Participation on PAR-19-368, Accelerating the Pace of Drug Abuse Research Using Existing Data | NOT-CA-20-061 | R01 | Clinical Trial Optional | September 08, 2021 | Carolyn Reyes-Guzman 240-276-7244 carolyn.reyes-guzman@nih.gov |
Notices - including Notices of Special Interest (NOSIs) | Tobacco Control Research, Basic Biobehavioral and Psychological Sciences, Health Behaviors Research |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-893 | R01 | Clinical Trial Optional | September 08, 2021 | Frank Perna 240-276-6782 pernafm@mail.nih.gov |
PAR | Cancer Survivorship, Health Behaviors Research |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-892 | R21 | Clinical Trial Optional | September 08, 2021 | Frank Perna 240-276-6782 pernafm@mail.nih.gov |
PAR | Cancer Survivorship, Health Behaviors Research |
| Diet and Physical Activity Assessment Methodology | PAR-18-857 | R21 | Clinical Trial Not Allowed | September 08, 2021 | Richard Troiano 240-276-6916 troianor@mail.nih.gov Kirsten Herrick 240-276-5734 herrickka@mail.nih.gov |
PAR | Epidemiology and Genomics Research |
| Diet and Physical Activity Assessment Methodology | PA-18-856 | R01 | Clinical Trial Not Allowed | September 08, 2021 | Richard Troiano 240-276-6916 troianor@mail.nih.gov Kirsten Herrick 240-276-5734 herrickka@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study | PAR-19-162 | R01 | Clinical Trial Not Allowed | September 08, 2021 | Annette Kaufman 240-276-6706 kaufmana@mail.nih.gov |
PAR | Tobacco Control Research |
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study | PAR-19-163 | R21 | Clinical Trial Not Allowed | September 08, 2021 | Annette Kaufman 240-276-6706 kaufmana@mail.nih.gov |
PAR | Tobacco Control Research |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility | PA-18-678 | R21 | Clinical Trial Not Allowed | May 08, 2021 | Tram Lam 240-276-6967 lamt@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer | PA-18-492 | R21 | Clinical Trial Optional | May 08, 2021 | Gurvaneet Randhawa 240-276-6940 gurvaneet.randhawa@nih.gov |
PA | Healthcare Delivery Research, Cancer Survivorship, Implementation Science |
| Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer | PA-18-493 | R01 | Clinical Trial Optional | May 08, 2021 | Gurvaneet Randhawa 240-276-6940 gurvaneet.randhawa@nih.gov |
PA | Healthcare Delivery Research, Cancer Survivorship, Implementation Science |
| End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness | PA-18-498 | R01 | Clinical Trial Optional | May 08, 2021 | Sylvia Chou 240-276-6954 chouws@mail.nih.gov |
PA | Health Communication and Informatics Research, Cancer Survivorship |
| Secondary Analyses of Existing Datasets of Tobacco Use and Health | RFA-OD-19-022 | R21 | Clinical Trial Not Allowed | March 09, 2021 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery | PAR-19-373 | R01 | Clinical Trial Not Allowed | March 18, 2021 | Rebecca Ferrer 301-852-1167 rebecca.ferrer@nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery | PAR-19-384 | R01 | Basic Experimental Studies with Humans Required | March 18, 2021 | Rebecca Ferrer 301-852-1167 rebecca.ferrer@nih.gov |
PAR | Basic Biobehavioral and Psychological Sciences |
| Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" | NOT-OD-20-103 | March 18, 2021 | Rebecca Ferrer |
Notices - including Notices of Special Interest (NOSIs) | Basic Biobehavioral and Psychological Sciences | ||
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers | PA-18-738 | R01 | Clinical Trial Optional | May 08, 2021 | Tram Lam 240-276-6967 lamt@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers | PA-18-739 | R21 | Clinical Trial Optional | May 08, 2021 | Tram Lam 240-276-6967 lamt@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility | PA-18-677 | R01 | Clinical Trial Not Allowed | May 08, 2021 | Tram Lam 240-276-6967 lamt@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Testing Interventions for Health-Enhancing Physical Activity | PAR-18-324 | R01 | Clinical Trial Optional | May 08, 2021 | Frank Perna |
PAR | Health Behaviors Research |
| Developing Interventions for Health-Enhancing Physical Activity | PAR-18-307 | R21, R33 | Clinical Trial Optional | May 08, 2021 | Frank Perna |
PAR | Health Behaviors Research |
| Notice of Special Interest (NOSI) Research to Advance the Understanding of Tobacco Product Pharmacokinetic Research | NOT-OD-20-081 | February 13, 2021 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
Notices - including Notices of Special Interest (NOSIs) | Tobacco Control Research | ||
| Tobacco Regulatory Science | RFA-OD-19-028 | R01 | Clinical Trial Optional | February 14, 2021 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors | PAR-19-018 | R01 | Clinical Trial Not Allowed | March 05, 2021 | Damali Martin 240-276-6746 martinda@mail.nih.gov |
PAR | Health Disparities, Epidemiology and Genomics Research |
| Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors | PAR-19-019 | R21 | Clinical Trial Not Allowed | March 05, 2021 | Damali Martin 240-276-6746 martinda@mail.nih.gov |
PAR | Health Disparities, Epidemiology and Genomics Research |
| Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities | PAR-19-093 | R01 | Clinical Trial Optional | March 05, 2021 | April Oh 240-276-6709 april.oh@nih.gov |
PAR | Health Communication and Informatics Research, Implementation Science |
| Modular R01s in Cancer Control and Population Sciences | PAR-18-869 | R01 | Clinical Trial Optional | March 09, 2021 | Scott Rogers 240-276-6932 rogerssc@mail.nih.gov |
PAR | Parent and Omnibus Funding Announcements, Epidemiology and Genomics Research, Implementation Science |
| Maximizing the Scientific Value of Existing Biospecimen Collections | RFA-OD-19-021 | R21 | Clinical Trial Not Allowed | March 09, 2021 | Rachel Grana Mayne 240-276-5899 rachel.mayne@nih.gov |
RFA | Tobacco Control Research |
| Early-life Factors and Cancer Development Later in Life | PA-18-532 | R21 | Clinical Trial Not Allowed | January 08, 2021 | Somdat Mahabir 240-276-6941 Mahabir@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Academic Research Enhancement Award | PA-18-504 | R15 | January 08, 2021 | Shobha Srinivasan 240-276-6938 sriniva2@mail.nih.gov |
PA | Health Disparities | |
| Research Answers to National Cancer Institute's (NCI) Provocative Questions | RFA-CA-20-004 | R01 | Clinical Trial Optional | November 18, 2020 | Sean Hanlon |
RFA | Cancer Survivorship, Epidemiology and Genomics Research, Health Behaviors Research, Healthcare Delivery Research, Health Disparities, Parent and Omnibus Funding Announcements |
| Cancer Prevention and Control Clinical Trials Grant Program | PAR-21-035 | R01 | Clinical Trial Required | January 08, 2024 | Susan Czajkowski |
PAR | Implementation Science, Parent and Omnibus Funding Announcements |
| NIH Research Project Grant | PA-20-185 | R01 | Clinical Trial Not Allowed | May 08, 2023 | PA, Parent Announcements | Parent and Omnibus Funding Announcements | |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-313 | UH2, UH3 | Clinical Trial Not Allowed | October 11, 2023 | Mukesh Verma |
PAR | Epidemiology and Genomics Research |
| Early-life Factors and Cancer Development Later in Life | PA-18-531 | R03 | Clinical Trial Not Allowed | January 08, 2021 | Somdat Mahabir 240-276-6941 Mahabir@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Early-life Factors and Cancer Development Later in Life | PA-18-529 | R01 | Clinical Trial Not Allowed | January 08, 2021 | Somdat Mahabir 240-276-6941 Mahabir@mail.nih.gov |
PA | Epidemiology and Genomics Research |
| Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program | PAR-20-254 | R01 | July 23, 2023 | Charlisse Caga-anan |
PAR | Epidemiology and Genomics Research | |
| Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program | PAR-20-255 | R21 | July 20, 2023 | Charlisse Caga-anan |
PAR | Epidemiology and Genomics Research | |
| Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program | PAR-20-257 | R03 | July 20, 2023 | Charlisse Caga-anan |
PAR | Epidemiology and Genomics Research | |
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-276 | R01 | September 08, 2022 | Melissa Rotunno |
PAR | Epidemiology and Genomics Research | |
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-277 | R21 | September 08, 2022 | Melissa Rotunno |
PAR | Epidemiology and Genomics Research | |
| Intervention Research to Improve Native American Health | PAR-20-238 | R01 | September 08, 2023 | Shobha Srinivasan |
PAR | Health Disparities | |
| Research to Improve Native American Health (R21 Clinical Trials Optional) | PAR-20-214 | R21 | September 08, 2023 | Shobha Srinivasan |
PAR | Health Disparities | |
| Notice of Special Interest (NOSI): Smart and Connected Health (National Science Foundation - NIH Interagency Initiative) | NOT-OD-13-041 | April Oh |
Notices - including Notices of Special Interest (NOSIs) | Health Communication and Informatics Research |
Go to the Archive of Funding Opportunities for information on recent funding announcements. Visit the Cancer Control Research section of this website for descriptive information on currently funded grants in this area.